431 related articles for article (PubMed ID: 31914155)
1. Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome.
Mohamed A; Collins J; Jiang H; Molendijk J; Stoll T; Torta F; Wenk MR; Bird RJ; Marlton P; Mollee P; Markey KA; Hill MM
PLoS One; 2020; 15(1):e0227455. PubMed ID: 31914155
[TBL] [Abstract][Full Text] [Related]
2. Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma.
Khan MJ; Codreanu SG; Goyal S; Wages PA; Gorti SKK; Pearson MJ; Uribe I; Sherrod SD; McLean JA; Porter NA; Robinson RAS
Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8911. PubMed ID: 32738001
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive lipidomics of mouse plasma using class-specific surrogate calibrants and SWATH acquisition for large-scale lipid quantification in untargeted analysis.
Drotleff B; Illison J; Schlotterbeck J; Lukowski R; Lämmerhofer M
Anal Chim Acta; 2019 Dec; 1086():90-102. PubMed ID: 31561798
[TBL] [Abstract][Full Text] [Related]
4. The Power of LC-MS Based Multiomics: Exploring Adipogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.
Rampler E; Egger D; Schoeny H; Rusz M; Pacheco MP; Marino G; Kasper C; Naegele T; Koellensperger G
Molecules; 2019 Oct; 24(19):. PubMed ID: 31597247
[TBL] [Abstract][Full Text] [Related]
5. Integrated Lipidomics and Transcriptomics Characterization upon Aging-Related Changes of Lipid Species and Pathways in Human Bone Marrow Mesenchymal Stem Cells.
Lu X; Chen Y; Wang H; Bai Y; Zhao J; Zhang X; Liang L; Chen Y; Ye C; Li Y; Zhang Y; Li Y; Ma T
J Proteome Res; 2019 May; 18(5):2065-2077. PubMed ID: 30827117
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple Myeloma.
Martins CO; Huet S; Yi SS; Ritorto MS; Landgren O; Dogan A; Chapman JR
J Mol Diagn; 2020 Jul; 22(7):901-911. PubMed ID: 32302778
[TBL] [Abstract][Full Text] [Related]
7. Non-targeted lipidomics and transcriptomics analysis reveal the molecular underpinnings of mandibular gland development in Apis mellifera ligustica.
Hu X; Zhang W; Chi X; Wang H; Liu Z; Wang Y; Ma L; Xu B
Dev Biol; 2021 Nov; 479():23-36. PubMed ID: 34332994
[TBL] [Abstract][Full Text] [Related]
8. Lipidomics profiling of zebrafish liver through untargeted liquid chromatography-high resolution mass spectrometry.
da Silva KM; Iturrospe E; van den Boom R; van de Lavoir M; Robeyns R; Vergauwen L; Knapen D; Cuykx M; Covaci A; van Nuijs ALN
J Sep Sci; 2022 Aug; 45(15):2935-2945. PubMed ID: 35716100
[TBL] [Abstract][Full Text] [Related]
9. Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Gong LL; Yang S; Zhang W; Han FF; Lv YL; Xuan LL; Liu H; Liu LH
J Pharm Biomed Anal; 2020 Jan; 177():112848. PubMed ID: 31479998
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis in multiple myeloma research.
Cumova J; Potacova A; Zdrahal Z; Hajek R
Mol Biotechnol; 2011 Jan; 47(1):83-93. PubMed ID: 20730509
[TBL] [Abstract][Full Text] [Related]
11. Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.
Zeng W; Zheng W; Hu S; Zhang J; Zhang W; Xu J; Yu D; Peng J; Zhang L; Gong M; Wei Y
Technol Cancer Res Treat; 2021; 20():15330338211049903. PubMed ID: 34761720
[No Abstract] [Full Text] [Related]
12. Comparison of one-phase and two-phase extraction methods for porcine tissue lipidomics applying a fast and reliable tentative annotation workflow.
Bögl T; Mlynek F; Himmelsbach M; Buchberger W
Talanta; 2022 Jan; 236():122849. PubMed ID: 34635239
[TBL] [Abstract][Full Text] [Related]
13. Extracting Biological Insight from Untargeted Lipidomics Data.
Kyle JE
Methods Mol Biol; 2020; 2104():121-137. PubMed ID: 31953815
[TBL] [Abstract][Full Text] [Related]
14. Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism.
Scheidemantle G; Duan L; Lodge M; Cummings MJ; Hilovsky D; Pham E; Wang X; Kennedy A; Liu X
Metabolomics; 2024 May; 20(3):53. PubMed ID: 38722395
[TBL] [Abstract][Full Text] [Related]
15. Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics.
Merciai F; Musella S; Sommella E; Bertamino A; D'Ursi AM; Campiglia P
J Chromatogr A; 2022 Jun; 1673():463124. PubMed ID: 35567813
[TBL] [Abstract][Full Text] [Related]
16. One- vs two-phase extraction: re-evaluation of sample preparation procedures for untargeted lipidomics in plasma samples.
Gil A; Zhang W; Wolters JC; Permentier H; Boer T; Horvatovich P; Heiner-Fokkema MR; Reijngoud DJ; Bischoff R
Anal Bioanal Chem; 2018 Sep; 410(23):5859-5870. PubMed ID: 29968103
[TBL] [Abstract][Full Text] [Related]
17. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
[TBL] [Abstract][Full Text] [Related]
18. Lipidomic profiling of non-mineralized dental plaque and biofilm by untargeted UHPLC-QTOF-MS/MS and SWATH acquisition.
Drotleff B; Roth SR; Henkel K; Calderón C; Schlotterbeck J; Neukamm MA; Lämmerhofer M
Anal Bioanal Chem; 2020 Apr; 412(10):2303-2314. PubMed ID: 31942654
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of lipid quantification accuracy using HILIC and RPLC MS on the example of NIST® SRM® 1950 metabolites in human plasma.
Lange M; Fedorova M
Anal Bioanal Chem; 2020 Jun; 412(15):3573-3584. PubMed ID: 32240327
[TBL] [Abstract][Full Text] [Related]
20. On the future of "omics": lipidomics.
Griffiths WJ; Ogundare M; Williams CM; Wang Y
J Inherit Metab Dis; 2011 Jun; 34(3):583-92. PubMed ID: 21318352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
